NCT07311356

Brief Summary

The AM2P study aims to evaluate the long-term prognosis and quality of life of patients with early-onset anorexia nervosa, assessed 4 to 9 years after hospitalization. Prognosis will be determined using a composite outcome measure based on questionnaire responses and health indicators, including body mass index (BMI). In addition, the study will examine the patients' overall physical condition both at the time of assessment and during the interval between their last hospitalization and the present evaluation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 5, 2025

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

December 16, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 30, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

February 3, 2026

Status Verified

February 1, 2026

Enrollment Period

4 months

First QC Date

December 16, 2025

Last Update Submit

February 2, 2026

Conditions

Anorexia Nervosa

Keywords

early-onset anorexia nervosaquality of lifeprognosis

Outcome Measures

Primary Outcomes (1)

  • Score of Eating Disorder Examination Questionnaire (EDE SQ) scale

    the percentage of subjective cure

    6 months

Secondary Outcomes (1)

  • Identification of predictive factors at admission for the trajectory (remission/relapse)

    6 months

Study Arms (1)

Cohorte AM2P

Completion of quality of life questionnaire, clinic

Eligibility Criteria

Age0 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients suffering from early\_onset anorexia nervosa

You may qualify if:

  • First full hospitalization in the eating disorders unit (EDU) at Robert Debré Hospital and diagnosis of AMP from 2016 to 2021
  • No objection from the minor to the study
  • Proficiency and understanding of the French language
  • Access to digital technology (computer, smartphone, tablet, etc.)

You may not qualify if:

  • Primary diagnosis of ARFID, other unspecified eating disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Robert Debre - AP-HP

Paris, 75019, France

RECRUITING

MeSH Terms

Conditions

Anorexia Nervosa

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Officials

  • Coline STORDEUR, MD

    Assistance Publique Hopitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Coline STORDEUR, MD

CONTACT

33140032261coline.stordeur@aphp.fr

Anael AYROLLES, MD

CONTACT

33140032261anael.ayrolles@aphp.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2025

First Posted

December 30, 2025

Study Start

December 5, 2025

Primary Completion

March 31, 2026

Study Completion

March 31, 2026

Last Updated

February 3, 2026

Record last verified: 2026-02

Locations

FR(1)